| Henry Glen Strawn, LCSW | |
|
2707 Browns Lane, Jonesboro, AR 72401 | |
| (870) 972-4939 | |
| (870) 972-4911 |
| Full Name | Henry Glen Strawn |
|---|---|
| Gender | Male |
| Speciality | Clinical Social Worker |
| Experience | 31 Years |
| Location | 2707 Browns Lane, Jonesboro, Arkansas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1114972809 | NPI | - | NPPES |
| 5W402 | Other | AR | BLUECROSS BLUESHIELD |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1041C0700X | Social Worker - Clinical | 1442-C (Arkansas) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Families, Inc Of Arkansas | 9335133669 | 38 |
News Archive
Although gynecologic cancers account for only 10 percent of all new cancer cases in women, these cancers account for 20 percent of all female cancer survivors. Because long-term survival is now more common, it is increasingly important to detect recurrence.
CPEX Pharmaceuticals Inc. today announced that its partner, Serenity Pharmaceuticals, has entered into a global agreement with Allergan, Inc. for the development and commercialization of Ser-120, a product candidate currently in Phase III clinical trials for the treatment of nocturia that utilizes CPEX's patented intranasal drug delivery technology.
Investigation of the source of the current outbreak, first reported on 22 April, continues to focus on the National Institute of Virology in Beijing. The institute is known to have conducted experiments using the live SARS coronavirus during February and March.
ViroPharma Incorporated has announced that the U.S. Food and Drug Administration (FDA) has granted fast track designation for maribavir, an oral antiviral drug candidate for the prevention of cytomegalovirus (CMV) infection in allogeneic bone marrow (stem cell) and solid organ transplant patients.
› Verified 8 days ago
| Entity Name | Families, Inc Of Arkansas |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1770535569 PECOS PAC ID: 9335133669 Enrollment ID: O20040412000211 |
News Archive
Although gynecologic cancers account for only 10 percent of all new cancer cases in women, these cancers account for 20 percent of all female cancer survivors. Because long-term survival is now more common, it is increasingly important to detect recurrence.
CPEX Pharmaceuticals Inc. today announced that its partner, Serenity Pharmaceuticals, has entered into a global agreement with Allergan, Inc. for the development and commercialization of Ser-120, a product candidate currently in Phase III clinical trials for the treatment of nocturia that utilizes CPEX's patented intranasal drug delivery technology.
Investigation of the source of the current outbreak, first reported on 22 April, continues to focus on the National Institute of Virology in Beijing. The institute is known to have conducted experiments using the live SARS coronavirus during February and March.
ViroPharma Incorporated has announced that the U.S. Food and Drug Administration (FDA) has granted fast track designation for maribavir, an oral antiviral drug candidate for the prevention of cytomegalovirus (CMV) infection in allogeneic bone marrow (stem cell) and solid organ transplant patients.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Henry Glen Strawn, LCSW 2707 Browns Lane, Jonesboro, AR 72401 Ph: (870) 972-4939 | Henry Glen Strawn, LCSW 2707 Browns Lane, Jonesboro, AR 72401 Ph: (870) 972-4939 |
News Archive
Although gynecologic cancers account for only 10 percent of all new cancer cases in women, these cancers account for 20 percent of all female cancer survivors. Because long-term survival is now more common, it is increasingly important to detect recurrence.
CPEX Pharmaceuticals Inc. today announced that its partner, Serenity Pharmaceuticals, has entered into a global agreement with Allergan, Inc. for the development and commercialization of Ser-120, a product candidate currently in Phase III clinical trials for the treatment of nocturia that utilizes CPEX's patented intranasal drug delivery technology.
Investigation of the source of the current outbreak, first reported on 22 April, continues to focus on the National Institute of Virology in Beijing. The institute is known to have conducted experiments using the live SARS coronavirus during February and March.
ViroPharma Incorporated has announced that the U.S. Food and Drug Administration (FDA) has granted fast track designation for maribavir, an oral antiviral drug candidate for the prevention of cytomegalovirus (CMV) infection in allogeneic bone marrow (stem cell) and solid organ transplant patients.
› Verified 8 days ago
Angela Christine Smith, LCSW Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 615 E Matthews Ave, Jonesboro, AR 72401 Phone: 870-930-9090 | |
Miss Anna Gatlin, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 4508 Stadium Blvd, Jonesboro, AR 72404 Phone: 870-933-6886 Fax: 870-933-9395 | |
Kelli Leann Statler, LCSW Clinical Social Worker Medicare: Accepting Medicare Assignments Practice Location: 2707 Browns Ln, Jonesboro, AR 72401 Phone: 870-972-4939 Fax: 870-972-4911 | |
Destiny Mcgee, LCSW Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 2707 Browns Ln, Jonesboro, AR 72401 Phone: 870-972-4000 Fax: 870-972-4968 | |
Malory Paige Slater, LMSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 4802 E Johnson Ave, Jonesboro, AR 72405 Phone: 870-936-8000 Fax: 870-934-3649 | |
Ruth Ann Carpenter, LCSW Clinical Social Worker Medicare: Accepting Medicare Assignments Practice Location: 2707 Browns Ln, Jonesboro, AR 72401 Phone: 870-972-4939 Fax: 870-972-4911 | |
Natalie G Bland, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 2707 Browns Ln, Jonesboro, AR 72401 Phone: 870-972-4939 Fax: 870-972-4911 |